- $454.43m
- $1.07bn
- $90.40m
- 67
- 69
- 50
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 40.7 | 57 | 75.3 | 89.2 | 90.4 |
Cost of Revenue | |||||
Gross Profit | 34.6 | 51 | 66.5 | 78.2 | 77.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21.4 | 29.4 | 43.6 | 55.3 | 56.9 |
Operating Profit | 19.3 | 27.7 | 31.7 | 33.9 | 33.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.76 | 4.96 | 3.51 | 4.72 | 14.6 |
Net Income After Taxes | 1.76 | 4.96 | 3.51 | 4.72 | 14.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.74 | 4.93 | 3.5 | 4.71 | 14.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.5 | -4.4 | -8.76 | -15 | -9.85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.111 | -0.103 | -0.207 | -0.282 | -0.349 |
Dividends per Share |